Search - tctmd.com

Displaying 21 - 37 of 37

Sort: Relevancy | Date

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

Cryoballoon Gets FDA Approval for Persistent A-fib

Todd Neale

June 29, 2020

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Daily News

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

Yael L. Maxwell

December 05, 2018

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Caitlin E. Cox

September 05, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Michael O'Riordan

June 30, 2016

Advertisement

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

Funding the Future: How Industry Support for CV Trials Could Evolve

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Cryoballoon Gets FDA Approval for Persistent A-fib

European Regulators Approve First Transcatheter MV Replacement Device

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

FDA Extends MitraClip Indication to Include Functional MR

FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content